Back to Search
Start Over
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology
- Source :
- Clinical Research in Cardiology
- Publication Year :
- 2020
- Publisher :
- Springer Berlin Heidelberg, 2020.
-
Abstract
- The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.
- Subjects :
- medicine.medical_specialty
Side effect
Cancer therapy
medicine.medical_treatment
Medizin
Antineoplastic Agents
030204 cardiovascular system & hematology
German
03 medical and health sciences
0302 clinical medicine
Quality of life
Consensus Paper
Risk Factors
Internal medicine
Germany
Neoplasms
medicine
Chemotherapy
Humans
Adverse effect
Cardiotoxicity
Hematology
Radiotherapy
business.industry
General Medicine
Survivorship programs
Combined Modality Therapy
language.human_language
Radiation therapy
Cardio-oncology
Cardiovascular Diseases
030220 oncology & carcinogenesis
language
Cardiology
Quality of Life
Immunotherapy
Cardiology and Cardiovascular Medicine
business
Subjects
Details
- Language :
- English
- ISSN :
- 18610692 and 18610684
- Volume :
- 109
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Clinical Research in Cardiology
- Accession number :
- edsair.doi.dedup.....2e717477a9c3a0d72fa4368bf8eca392